| Product Code: ETC12473454 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
Ireland continues to rely on imports of induced pluripotent stem cells, with top suppliers including the USA, UK, Germany, Metropolitan France, and Serbia in 2024. The market shows high concentration levels with a very high Herfindahl-Hirschman Index (HHI) in the same year. However, there was a notable decline in the compound annual growth rate (CAGR) from 2020 to 2024 at -4.18%, with a sharp decrease in the growth rate from 2023 to 2024 at -30.16%. These trends indicate a challenging environment for the import market of induced pluripotent stem cells in Ireland.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Induced Pluripotent Stem Cells Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Induced Pluripotent Stem Cells Market - Industry Life Cycle |
3.4 Ireland Induced Pluripotent Stem Cells Market - Porter's Five Forces |
3.5 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume Share, By Source Type, 2021 & 2031F |
3.6 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume Share, By Differentiation Capability, 2021 & 2031F |
3.9 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume Share, By Research Stage, 2021 & 2031F |
4 Ireland Induced Pluripotent Stem Cells Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing research and development activities in the field of induced pluripotent stem cells in Ireland |
4.2.2 Rising prevalence of chronic diseases driving the demand for innovative treatment options |
4.2.3 Government initiatives and funding support for stem cell research in Ireland |
4.3 Market Restraints |
4.3.1 Ethical concerns and regulatory restrictions surrounding the use of induced pluripotent stem cells |
4.3.2 High cost associated with the development and commercialization of induced pluripotent stem cell therapies |
5 Ireland Induced Pluripotent Stem Cells Market Trends |
6 Ireland Induced Pluripotent Stem Cells Market, By Types |
6.1 Ireland Induced Pluripotent Stem Cells Market, By Source Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume, By Source Type, 2021 - 2031F |
6.1.3 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume, By Human iPSCs, 2021 - 2031F |
6.1.4 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume, By Mouse iPSCs, 2021 - 2031F |
6.1.5 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume, By Genetically Modified iPSCs, 2021 - 2031F |
6.1.6 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume, By Tissue-Specific iPSCs, 2021 - 2031F |
6.2 Ireland Induced Pluripotent Stem Cells Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume, By Disease Modeling, 2021 - 2031F |
6.2.3 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume, By Drug Discovery, 2021 - 2031F |
6.2.4 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume, By Stem Cell Therapy, 2021 - 2031F |
6.2.5 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.3 Ireland Induced Pluripotent Stem Cells Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.3 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume, By Academic Research Centers, 2021 - 2031F |
6.3.4 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.5 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume, By Biotech Companies, 2021 - 2031F |
6.4 Ireland Induced Pluripotent Stem Cells Market, By Differentiation Capability |
6.4.1 Overview and Analysis |
6.4.2 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume, By Multipotent, 2021 - 2031F |
6.4.3 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume, By Pluripotent, 2021 - 2031F |
6.4.4 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume, By Totipotent, 2021 - 2031F |
6.4.5 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume, By Oligopotent, 2021 - 2031F |
6.5 Ireland Induced Pluripotent Stem Cells Market, By Research Stage |
6.5.1 Overview and Analysis |
6.5.2 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume, By Preclinical Trials, 2021 - 2031F |
6.5.3 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
6.5.4 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume, By Commercial Development, 2021 - 2031F |
6.5.5 Ireland Induced Pluripotent Stem Cells Market Revenues & Volume, By -Ready Therapies, 2021 - 2031F |
7 Ireland Induced Pluripotent Stem Cells Market Import-Export Trade Statistics |
7.1 Ireland Induced Pluripotent Stem Cells Market Export to Major Countries |
7.2 Ireland Induced Pluripotent Stem Cells Market Imports from Major Countries |
8 Ireland Induced Pluripotent Stem Cells Market Key Performance Indicators |
8.1 Number of research grants allocated for induced pluripotent stem cell research in Ireland |
8.2 Percentage of successful clinical trials related to induced pluripotent stem cells in Ireland |
8.3 Adoption rate of induced pluripotent stem cell therapies in clinical settings in Ireland |
9 Ireland Induced Pluripotent Stem Cells Market - Opportunity Assessment |
9.1 Ireland Induced Pluripotent Stem Cells Market Opportunity Assessment, By Source Type, 2021 & 2031F |
9.2 Ireland Induced Pluripotent Stem Cells Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Ireland Induced Pluripotent Stem Cells Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Ireland Induced Pluripotent Stem Cells Market Opportunity Assessment, By Differentiation Capability, 2021 & 2031F |
9.5 Ireland Induced Pluripotent Stem Cells Market Opportunity Assessment, By Research Stage, 2021 & 2031F |
10 Ireland Induced Pluripotent Stem Cells Market - Competitive Landscape |
10.1 Ireland Induced Pluripotent Stem Cells Market Revenue Share, By Companies, 2024 |
10.2 Ireland Induced Pluripotent Stem Cells Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |